[ad_1]
The fourth shipment of Coronavac, a vaccine against Covid-19 produced by the Chinese company Sinovac in association with the Butantan Institute, in São Paulo, arrived this Thursday morning (24) at the Viracopos International Airport, in Campinas (SP).
The Secretary of Health of São Paulo, Jean Gorinchteyn, was present at the site to receive the shipment. This new batch contains 5.5 million doses of the immunizer.
See and read also:
The government of SP and Butantan postpone the disclosure of the effectiveness of Coronavac
Coronavac receives the certification of good manufacturing practices from Anvisa
The three previous shipments secured more than 3 million doses for the Butantan Institute. Final 2020 shipments are scheduled for the 28th, with 400,000 doses, and the 30th, with more than 1.6 million doses.
In a press conference held on Wednesday (23), the São Paulo state government and the Butantan Institute affirmed that Coronavac reached the level of effectiveness required by the National Health Surveillance Agency (Anvisa) and the World Health Organization (WHO ), of at least 50%, in phase 3 of the surveys.
However, the degree of effectiveness achieved by the immunizer in the final phase of testing has not been revealed, as promised. The São Paulo government had already committed to releasing the detailed results of phase 3 of the studies last week, but again postponed the release of this information for contractual reasons.
At the beginning of the week, the immunizer was the first vaccine to receive Good Manufacturing Practice certification from Anvisa. On Wednesday, the Astrazeneca vaccine in partnership with the University of Oxford was the newest drug against Covid-19 to receive certification.
